Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001140361-21-002736
Filing Date
2021-01-29
Accepted
2021-01-29 17:23:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 29228
  Complete submission text file 0001140361-21-002736.txt   30127
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations